The World Health Organization (WHO) on Thursday issued an emergency use listing for the single-dose COVID-19 vaccine from China-based CanSino Biologics.
The vaccine, Convidecia, is the eleventh shot against the coronavirus to get clearance from the global health agency, whose advisory group recommended its use in people of age 18 years and above.
It was found to have 64 per cent efficacy against symptomatic disease and 92 per cent against severe COVID-19, the agency said.
Other vaccines that have similar clearance from the agency include those made by Pfizer and BioNTech, Moderna, AstraZeneca, Johnson & Johnson and Novavax.
At least 14 killed in explosion at weapons depot in Syria
US hits five Iranian oil tankers after attack on Navy ships
UK gives air traffic provider a week to probe outage that halted flights
Serbia's President Vucic dissolves parliament, calls snap elections
With large crowds attending, Norway lays King Harald to rest
Jordan intercepts 18 Iranian ballistic missiles
Air traffic control issue disrupts flights at major UK airports
At least 73 injured after Houthi rebels attack Saudi civilian and energy facilities
